Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. 2004

Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
Departamento de Farmacia e Tecnoloxía Farmacéutica, Facultade de Farmacia, Universidade de Santiago de Compostela, Campus Sur, E-15782, Santiago de Compostela, Spain.

This paper reports on the effect of beta-cyclodextrin (beta-CD) and hydroxypropyl-beta-cyclodextrin (HP-beta-CD) on the diffusion and the release behavior of diclofenac sodium and sulphamethizole from HPMC K4M gels and matrix tablets. The gels were prepared with 0.5-2.0% polymer and different drug/CD mole ratios, and their viscosity, cloud point and drug diffusion coefficients were estimated. No differences in cloud point were observed. The viscosity of the gels strongly depended on HPMC proportions (from 0.7 to 100 mPa.s), which affected to a lesser extent the resistance to the diffusion of the drugs (D values from 60 x 10(-6) to 5 x 10(-6) cm(2)/s). The influence of CD on diffusion was particularly evident in gels prepared with polymer proportions above its entanglement concentration, 2.0% HPMC K4M. In these systems, while high drug/CD proportions enhanced the diffusivity preventing polymer/drug hydrophobic interactions, low drug/CD ratios hindered it. An excess of free CD, especially the bulky HP-beta-CD, made the diffusion of the complexes in the relatively low mesh size 2% polymer network more difficult. In the case of tablets, CD plays an additional role as dissolution rate promoter. To evaluate to what extent the balance between the increase in dissolution rate and the decrease in diffusion rate induced by CD determines drug release, matrix tablets were prepared by direct compression of 100 mg drug and 400 mg polymer/CD/lactose blends, whose composition was chosen following a simplex centroid design. A higher CD/lactose ratio significantly increased the release rate of hydrophobic drugs (sulphamethizole), but decreased the release rate of hydrophilic drugs (diclofenac sodium), indicating the predominance of a different contribution depending on the hydrophilicity of the drug. Therefore, the use of CD derivatives may be particularly useful to modulate drug release from HPMC gels and matrix tablets; the influence of these additives being dependent on the nature of the drug and on the molecular size and hydrophilic character of the CD used.

UI MeSH Term Description Entries
D008747 Methylcellulose Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative. BFL,Celevac,Cellothyl,Cellulone,Citrucel,Cologel,Dacryolarmes,Methocel,Methyl Cellulose,Muciplasma,Cellulose, Methyl
D003505 Cyclodextrins A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. Cycloamylose,Cyclodextrin,Cyclodextrin Derivatives,Cyclomaltooligosaccharides,Derivatives, Cyclodextrin
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013608 Tablets, Enteric-Coated Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed) Enteric-Coated Tablets,Tablets, Enteric Coated
D065347 Hypromellose Derivatives Polymeric compounds that contain repeating units of hydroxypropyl methylcellulose. The properties of hypromellose polymers can vary greatly and are defined by their molecular weight, the percentage of hydroxyl groups, the percentage of hydroxypropyl groups, and viscosity measurements. They are found a broad variety of commercial products such as FOOD ADDITIVES; EXCIPIENTS; and LUBRICANTS. HPMC 2910,HPMC-K-100 M,Hydroxypropyl Methylcellulose,Hydroxypropylmethylcellulose,Hypromellose,K-8515,K8515,MHPC Polymer,Methocel E,Methoxyhydroxypropylcellulose,Methyl Hydroxypropyl Cellulose,Methyl-hydroxypropyl-cellulose,Derivative, Hypromellose,Derivatives, Hypromellose,HPMC K 100 M,HPMCK100 M,Hypromellose Derivative,K 8515

Related Publications

Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
July 2011, International journal of pharmaceutics,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
December 2010, International journal of pharmaceutics,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
April 2003, Journal of controlled release : official journal of the Controlled Release Society,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
October 2009, Drug development and industrial pharmacy,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
January 1999, Journal of pharmaceutical sciences,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
August 2000, Die Pharmazie,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
December 2010, Drug development and industrial pharmacy,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
June 2001, AAPS PharmSciTech,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
December 1996, Journal of veterinary pharmacology and therapeutics,
Beatriz Pose-Vilarnovo, and Carmen Rodríguez-Tenreiro, and José Fernando Rosa dos Santos, and Juan Vázquez-Doval, and Angel Concheiro, and Carmen Alvarez-Lorenzo, and Juan J Torres-Labandeira
September 1999, Drug development and industrial pharmacy,
Copied contents to your clipboard!